Spain (ES)

Gas Sensing Discrimination using a Cellular Nonlinear Network (2021) Al Chawa MM, Picos R, Panes-Ruiz LA, Riemenschneider L, Ibarlucea B, Cuniberti G, Tetzlaff R Conference contribution Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial. (2021) Wang Y, Pan Y, Li H, Amarenco P, Denison H, Evans SR, Himmelmann A, et al. Journal article Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes. (2021) Acosta-Herrera M, Kerick M, Lopez-Isac E, Assassi S, Beretta L, Simeon-Aznar CP, Ortego-Centeno N, et al. Journal article Implantación de un Sistema de Seguimiento de la Formación de los MOOC (2021) Díaz P, Belda Anaya R, Eugenio D, Formica C, Dimopoulou N, Kazantzidou N, Protopsaltis A, et al. Conference contribution, Conference Contribution Imaging the root–rhizosphere interface using micro computed tomography: quantifying void ratio and root volume ratio profiles (2021) Lascurain T, Angelidakis V, Luli S, Nadimi S Conference contribution, Original article Comparing open-source DEM frameworks for simulations of common bulk processes (2021) Dosta M, André D, Angelidakis V, Caulk R, Celigueta MÁ, Chareyre B, Dietiker JF, et al. Conference contribution, Abstract of lecture Corrigendum to: More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis. (2021) Parma V, Ohla K, Veldhuizen MG, Niv MY, Kelly CE, Bakke AJ, Cooper KW, et al. Journal article, Erratum Results of the Translation Inference Across Dictionaries 2021 Shared Task (2021) Gracia J, Kabashi B, Kernerman I Conference contribution Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. (2021) Bottomley A, Coens C, Mierzynska J, Blank CU, Mandalà M, Long GV, Atkinson VG, et al. Journal article Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. (2021) Eggermont AM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, et al. Journal article